Chisom Umejiaku
Biotechnology researchers have expressed optimism that new scientific breakthroughs could lead to effective cures for some of the world’s most challenging diseases, including cancer, diabetes, and neurodegenerative disorders.
Speaking at the Global Biotechnology Conference held in Geneva on Tuesday, August 19, 2025, experts highlighted advances in gene editing, precision medicine, and stem cell therapy as major drivers of progress.
They said these innovations are beginning to show promising results in clinical trials, raising hopes for treatments that go beyond managing symptoms to potentially reversing diseases.
Dr. Maria Hoffmann, a leading geneticist from the Max Planck Institute, said recent applications of CRISPR-Cas9 technology are enabling scientists to directly repair faulty genes responsible for hereditary illnesses.
READ ALSO: US Surgeon Makes History with Remote Robotic Cancer Surgery on Angolan Patient
Similarly, breakthroughs in immunotherapy are improving survival rates for certain cancers once considered untreatable.
While acknowledging the high cost of research and ethical concerns surrounding genetic modification, the experts stressed that collaboration between governments, the private sector, and academia would be critical to ensuring equitable access to new therapies.
The global biotechnology industry is projected to grow significantly over the next decade, driven by rising demand for innovative treatments and the urgent need to tackle both non-communicable and infectious diseases.